These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 17563714)
1. [Pharmacopeia and preparations for cutaneous application]. Esnault F; Etchegaray JP; Mallard C Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714 [No Abstract] [Full Text] [Related]
2. Ingredients in pharmaceutical preparations: a problem not value. Lubner GC Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372 [No Abstract] [Full Text] [Related]
3. [What has become of extemporaneous mixtures?]. Brasseur D Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S37-9. PubMed ID: 17563713 [No Abstract] [Full Text] [Related]
5. The United States Pharmacopeia. Its value to the professions. Heller WM JAMA; 1970 Jul; 213(4):576-9. PubMed ID: 4914287 [No Abstract] [Full Text] [Related]
6. Standardization of forensic drug analyses. Frank RS; Gunn JW J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386 [No Abstract] [Full Text] [Related]
7. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
8. [The role of biopharmaceutical parameters in drug development (author's transl)]. Thoma K Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191 [TBL] [Abstract][Full Text] [Related]
9. [ICH4 and pharmacopoeias: similarities and differences]. Artiges A Ann Pharm Fr; 1999 Mar; 57(2):161-7. PubMed ID: 10365473 [TBL] [Abstract][Full Text] [Related]
10. How good are our drugs? Miller LC Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276 [No Abstract] [Full Text] [Related]
11. Pharmaceutical analysis: key to drug quality and control. Florey KG; Brewer GA Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421 [No Abstract] [Full Text] [Related]
12. Relationship of USP-NF to NDA and ANDA "Standards". Belson JJ Am J Hosp Pharm; 1982 May; 39(5):869-70. PubMed ID: 7081269 [No Abstract] [Full Text] [Related]
14. Public standards for drugs: reflections on their use by the professions and industry. Miller LC Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682 [No Abstract] [Full Text] [Related]
15. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities. Williams RL; ; J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277 [TBL] [Abstract][Full Text] [Related]
16. Equivalence studies for complex active ingredients and dosage forms. Bhattycharyya L; Dabbah R; Hauck W; Sheinin E; Yeoman L; Williams R AAPS J; 2005 Nov; 7(4):E786-812. PubMed ID: 16594632 [TBL] [Abstract][Full Text] [Related]
17. Design and international harmonization of pharmacopoeial standards. Calam DH J Pharm Biomed Anal; 1995 Dec; 14(1-2):1-5. PubMed ID: 8833960 [TBL] [Abstract][Full Text] [Related]
18. Drug product equivalence--the problem, the challenge, and the U.S.P. Macek TJ Am J Pharm Sci Support Public Health; 1971; 143(6):188-94. PubMed ID: 5140167 [No Abstract] [Full Text] [Related]
19. GMPs vs GCPs: United States Pharmacopeia General Chapters. Allen LV Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791 [No Abstract] [Full Text] [Related]
20. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding. Hyde TD Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]